Table 1.
Summary of the two-way repeated measures ANOVA analysis results of alkaloids, chalcones and isothiocyanates in SK-LU-1 and HLCSC.
| Phytochemical Category |
Phytochemical Compound | Cell Line | Independent Variables |
Results |
|---|---|---|---|---|
| Isothiocyanate | BI | SK-LU-1 | Time | F (184, 1288) = 992.6, p < 0.0001, R2 = 0.08 |
| Treatment | F (6, 1288) = 1095, p < 0.0001, R2 = 0.79 | |||
| Interaction | F (1104, 1288) = 250.8, p < 0.0001, R2 = 0.13 | |||
| HLCSC | Time | F (184, 1288) = 352.5, p < 0.0001, R2 = 0.12 | ||
| Treatment | F (6, 1288) = 301.2, p < 0.0001, R2 = 0.65 | |||
| Interaction | F (1104, 1288) = 105.6, p < 0.0001, R2 = 0.22 | |||
| PI | SK-LU-1 | Time | F (184, 1288) = 195.1, p < 0.0001, R2 = 0.03 | |
| Treatment | F (6, 1288) = 1584, p < 0.0001, R2 = 0.85 | |||
| Interaction | F (1104, 1288) = 116.9, p < 0.0001, R2 = 0.12 | |||
| HLCSC | Time | F (184, 1288) = 4931, p < 0.0001, R2 = 0.16 | ||
| Treatment | F (6, 1288) = 777.7, p < 0.0001, R2 = 0.67 | |||
| Interaction | F (1104, 1288) = 851.8, p < 0.0001, R2 = 0.17 | |||
| Chalcone | LICO | SK-LU-1 | Time | F (184, 1288) = 362.4, p < 0.0001, R2 = 0.11 |
| Treatment | F (6, 1288) = 180.9, p < 0.0001, R2 = 0.78 | |||
| Interaction | F (1104, 1288) = 56.6, p < 0.0001, R2 = 0.10 | |||
| HLCSC | Time | F (184, 1288) = 1362, p < 0.0001, R2 = 0.27 | ||
| Treatment | F (6, 1288) = 201, p < 0.0001, R2 = 0.55 | |||
| Interaction | F (1104, 1288) = 149.5, p < 0.0001, R2 = 0.18 | |||
| ISO | SK-LU-1 | Time | F (184, 1288) = 365.3, p < 0.0001, R2 = 0.12 | |
| Treatment | F (6, 1288) = 307.5, p < 0.0001, R2 = 0.75 | |||
| Interaction | F (1104, 1288) = 62, p < 0.0001, R2 = 0.13 | |||
| HLCSC | Time | F (184, 1288) = 1985, p < 0.0001, R2 = 0.31 | ||
| Treatment | F (6, 1288) = 362.8, p < 0.0001, R2 = 0.52 | |||
| Interaction | F (1104, 1288) = 175.1, p < 0.0001, R2 = 0.17 | |||
| Alkaloid | EVO | SK-LU-1 | Time | F (184, 1288) = 151.7, p < 0.0001, R2 = 0.08 |
| Treatment | F (6, 1288) = 52.7, p < 0.0001, R2 = 0.76 | |||
| Interaction | F (1104, 1288) = 47.9, p < 0.0001, R2 = 0.15 | |||
| HLCSC | Time | F (184, 1288) = 1929, p < 0.0001, R2 = 0.48 | ||
| Treatment | F (6, 1288) = 206.3, p < 0.0001, R2 = 0.33 | |||
| Interaction | F (1104, 1288) = 130.5, p < 0.0001, R2 = 0.19 | |||
| CHE | SK-LU-1 | Time | F (184, 1288) = 59.4, p < 0.0001, R2 = 0.06 | |
| Treatment | F (6, 1288) = 38.9, p < 0.0001, R2 = 0.74 | |||
| Interaction | F (1104, 1288) = 31.4, p < 0.0001, R2 = 0.18 | |||
| HLCSC | Time | F (184, 1288) = 328.3, p < 0.0001, R2 = 0.49 | ||
| Treatment | F (6, 1288) = 121.8, p < 0.0001, R2 = 0.34 | |||
| Interaction | F (1104, 1288) = 17.2, p < 0.0001, R2 = 0.16 | |||
| Positive control | SAL | SK-LU-1 | Time | F (184, 1288) = 71.5, p < 0.0001, R2 = 0.04 |
| Treatment | F (6, 1288) = 80.9, p < 0.0001, R2 = 0.79 | |||
| Interaction | F (1104, 1288) = 47.1, p < 0.0001, R2 = 0.16 | |||
| HLCSC | Time | F (184, 1288) = 933.5, p < 0.0001, R2 = 0.15 | ||
| Treatment | F (6, 1288) = 591.4, p < 0.0001, R2 = 0.65 | |||
| Interaction | F (1104, 1288) = 205.4, p < 0.0001, R2 = 0.20 |